Abstract
Colorectal cancer is the most common cancer of the gastrointestinal system and has a marked preference to metastasize to distant organs. In this study, we investigated whether levels of circulating serum pro-angiogenic cytokine such as chemokine (C-X-C motif) ligand 1 (melanoma growth-stimulating activity, alpha; CXCL1) and vascular endothelial growth factor (VEGF) have a role in favoring the colonization of metastatic cells at preferential sites and determined their prognostic significance in a cohort of 103 patients with metastatic colorectal cancer. Importantly, we found that the presence of elevated circulating levels of VEGF and CXCL1 are predictive of liver and lung metastasis, respectively. Moreover, the presence of a high serum VEGF level represents a negative prognostic factor for patients with liver metastases, with a worse prognosis than patients with lung metastasis. This suggests an additional role for circulating cytokines as a predictive tool for cancer prognosis and diagnosis, as well as for assessment of tumor sensitivity to anticancer therapy.
Keywords
CXCL1
Metastasis
VEGF
angiogenesis
MeSH Terms
Adult
Aged
Aged, 80 and over
Chemokine CXCL1/blood
Colorectal Neoplasms/blood,pathology
Female
Humans
Liver Neoplasms/blood,secondary
Lung Neoplasms/blood,secondary
Male
Middle Aged
Neoplasm Metastasis
Prognosis
Survival Analysis
Vascular Endothelial Growth Factor A/blood
Chemicals
CXCL1 protein, human
Chemokine CXCL1
Vascular Endothelial Growth Factor A
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Divella Rosa
Clinical Pathology Laboratory, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy
[email protected].
Daniele Antonella
Clinical Pathology Laboratory, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
DE Luca Raffaele
Department of Surgery Oncology, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
Simone Michele
Department of Surgery Oncology, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
Naglieri Emanuele
Department of Medical Oncology, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
Savino Eufemia
Clinical Pathology Laboratory, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
Abbate Ines
Clinical Pathology Laboratory, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
Gadaleta Cosmo Damiano
Diagnostic and Interventional Radiology Unit with Integrated Section of Translational Medical Oncology, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.
Ranieri Girolamo
Diagnostic and Interventional Radiology Unit with Integrated Section of Translational Medical Oncology, National Cancer Research Centre, Giovanni Paolo II Tumor institute, Bari, Italy.